SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042481
Filing Date
2018-08-07
Accepted
2018-08-07 17:01:47
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv498756_10q.htm 10-Q 794069
2 EXHIBIT 10.1 tv498756_ex10-1.htm EX-10.1 34463
3 EXHIBIT 10.2 tv498756_ex10-2.htm EX-10.2 46936
4 EXHIBIT 31.1 tv498756_ex31-1.htm EX-31.1 7980
5 EXHIBIT 31.2 tv498756_ex31-2.htm EX-31.2 7954
6 EXHIBIT 32.1 tv498756_ex32-1.htm EX-32.1 5719
  Complete submission text file 0001144204-18-042481.txt   5792376

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT icpt-20180630.xml EX-101.INS 1688178
8 XBRL TAXONOMY EXTENSION SCHEMA icpt-20180630.xsd EX-101.SCH 36049
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20180630_cal.xml EX-101.CAL 47824
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20180630_def.xml EX-101.DEF 104708
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20180630_lab.xml EX-101.LAB 296739
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20180630_pre.xml EX-101.PRE 255844
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 18998902
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences